Cargando…

Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic

We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rose, Ashley N, Baggs, James, Wolford, Hannah, Neuhauser, Melinda M, Srinivasan, Arjun, Gundlapalli, Adi V, Reddy, Sujan, Kompaniyets, Lyudmyla, Pennington, Audrey F, Grigg, Cheri, Kabbani, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244661/ https://www.ncbi.nlm.nih.gov/pubmed/34226869 http://dx.doi.org/10.1093/ofid/ofab236

Ejemplares similares

Empiric antibiotic selection for community-acquired pneumonia in US hospitals, 2013–2020
por: Wolford, Hannah, et al.
Publicado: (2023)

Estimation of Coronavirus Disease 2019 Hospitalization Costs From a Large Electronic Administrative Discharge Database, March 2020–July 2021
por: Shrestha, Sundar S, et al.
Publicado: (2021)

Length of antibiotic therapy among adults aged ≥65 years hospitalized with uncomplicated community-acquired pneumonia, 2013-2020
por: McCarthy, Natalie, et al.
Publicado: (2023)

1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021
por: Wolford, Hannah, et al.
Publicado: (2023)

2473. Rates of Antibiotic Resistant Infections in Hospitalized Patients with Hematologic and Non-Hematologic Cancers, 2019
por: McCarthy, Natalie, et al.
Publicado: (2023)

24. Antibiotic Use in Hospital Emergency Departments and Observation Settings from 2012–2018 in a Large Cohort of U.S. Hospitals
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

2891. Trends in Inpatient Antibiotic Use in US Hospitals, 2012–2017
por: Baggs, James, et al.
Publicado: (2019)

2472. Hospital Onset Antibiotic Resistant Infections among Patients without COVID-19 Diagnosis in Pre-Pandemic and Pandemic Periods
por: Baggs, James, et al.
Publicado: (2023)

427. Trends in Hospital-onset Escherichia coli Infections Resistant to Fluoroquinolones and Extended-spectrum Cephalosporins, 2012-2020
por: Hood, Nicole, et al.
Publicado: (2022)

2455. National Trends in the Rates of Drug-resistant Bacteria Commonly Associated with Healthcare in U.S. Acute Care Hospitals, 2019-2021
por: Baggs, James, et al.
Publicado: (2023)

Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19—United States, March–September 2020
por: Pennington, Audrey F, et al.
Publicado: (2020)

2479. Trends and Regional Differences in Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, 2012–2017
por: Wolford, Hannah, et al.
Publicado: (2019)

Fluconazole resistance in non-albicans Candida species in the United States, 2012-2021
por: Jenkins, Emily, et al.
Publicado: (2023)

Description of antibiotic stewardship expertise and activities among US public health departments, 2022
por: Bizune, Destani, et al.
Publicado: (2023)

Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2021)

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2021)

Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2021)

Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2022)

Modeling the relationship between wolf control and cattle depredation
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2017)

121. Temporal Trends in Urine Culture Rates in the U.S. Acute Care Hospitals During 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2020)

Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission — United States, March–August 2020
por: Lavery, Amy M., et al.
Publicado: (2020)

Declines in the utilization of hospital‐based care during COVID‐19 pandemic
por: Kazakova, Sophia V., et al.
Publicado: (2022)

2463. Increased Rates of Candida Bloodstream Infections Associated with Drug Use, United States 2012–2017
por: McCarthy, Natalie, et al.
Publicado: (2019)

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021
por: Boehmer, Tegan K., et al.
Publicado: (2021)

545. Incidence of Carbapenem Non-Susceptible Acinetobacter spp. and Carbapenem-Resistant Pseudomonas aeruginosa Clinical Cultures among Patients in US Acute Care Hospitals, 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2019)

2850. Burden of Difficult-to-Treat Antibiotic-Resistant (DTR) Gram-Negative Infections in the United States, 2012–2017
por: Kadri, Sameer S, et al.
Publicado: (2019)

Temporal trends in urine-culture rates in the US acute-care hospitals, 2017–2020
por: Kazakova, Sophia, et al.
Publicado: (2022)

Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005–2010
por: Huttner, Benedikt, et al.
Publicado: (2012)

Uncovering gut microbiota-mediated indirect effects of antibiotic use on Clostridioides difficile transmission
por: Gowler, Camden, et al.
Publicado: (2023)

Factors Associated With Inter-Hospital Variability of Inpatient Antibiotic Use in a Cohort of US Hospitals
por: Baggs, James, et al.
Publicado: (2015)

845. Trends and Regional Differences in Community-Onset Fluoroquinolone-Resistant E. coli in Hospitalized Adults in the United States
por: Wolford, Hannah, et al.
Publicado: (2020)

12. Development of Provider-Specific Antibiotic Prescribing Feedback for Inpatient Antibiotic Stewardship Programs in Veterans Affairs (VA) Facilities (ASP)
por: Goetz, Matthew B, et al.
Publicado: (2021)

558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections
por: Gouin, Katryna, et al.
Publicado: (2019)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

National Healthcare Safety Network Antimicrobial Use Option reporting … finding the path forward
por: Neuhauser, Melinda M., et al.
Publicado: (2023)

916. National Estimates of the Proportion of Bacterial Pathogens Expressing Resistant Phenotypes in US Hospitals, 2012-2017
por: Baggs, James, et al.
Publicado: (2020)

Direct Medical Costs Associated With Post–COVID-19 Conditions Among Privately Insured Children and Adults
por: Pike, Jamison, et al.
Publicado: (2023)

1686. Microbiology of Community-Onset Urinary Tract Infections in the United States, 2012-2017
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016
por: Kabbani, Sarah, et al.
Publicado: (2019)

The effects of policy changes and human mobility on the COVID-19 epidemic in the Dominican Republic, 2020–2021
por: Maloney, Patrick, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rd660kok7k06s393hno4pl5pts